4//SEC Filing
van Dijk Marcus Antonius 4
Accession 0000899243-23-001622
CIK 0001840229other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 5:26 PM ET
Size
5.7 KB
Accession
0000899243-23-001622
Insider Transaction Report
Form 4
van Dijk Marcus Antonius
Chief Technology Officer
Transactions
- Award
Stock Option
2023-01-09+15,000→ 15,000 totalExercise: $2.32Exp: 2033-01-09→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]Option was granted on January 9, 2023 and awarded in accordance with the MiNK Therapeutics, Inc. 2021 Equity Incentive Plan. Option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the grant date, with the remainder vesting in equal quarterly installments thereafter.
Documents
Issuer
MiNK Therapeutics, Inc.
CIK 0001840229
Entity typeother
Related Parties
1- filerCIK 0001881659
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 5:26 PM ET
- Size
- 5.7 KB